Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG

Overview of attention for article published in Frontiers in immunology, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 5 X users

patent: 1 patent

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 41,028 followers.

Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG https://t.co/zpfLb9ZWlc

11 Apr 2023

Reply Repost Favourite

Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG https://t.co/dmpNTMzpoU

10 Apr 2023

Reply Repost Favourite

New Research: Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG: Currently licensed vaccine adjuvants offer limited mucosal immunity, which is needed to… https://t.co/1AcT

25 Mar 2023

Reply Repost Favourite

RT @AinslieLab: Check out our latest article: "Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled…

25 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.